Overview
Measles virus vaccine live attenuated is a live virus vaccine for simultaneous vaccination against measles, which is a common childhood disease. The vaccine is prepared from the attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture.
Indication
Measles virus vaccine is used to prevent measles in combination with other virus vaccines, such as the rubella and Mumps virus vaccine.
Associated Conditions
- Measles
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Nutritional Specialties, Inc. | 83027-0050 | ORAL | 16 [hp_X] in 1 mL | 5/21/2025 | |
Nutritional Specialties, Inc. | 83027-0071 | ORAL | 30 [hp_X] in 1 mL | 5/15/2025 | |
Deseret Biologicals, Inc. | 43742-2145 | ORAL | 12 [hp_X] in 1 mL | 5/27/2025 | |
Deseret Biologicals, Inc. | 43742-2266 | ORAL | 12 [hp_X] in 1 mL | 5/6/2025 | |
The Wellness Center for Research and Education, Inc. | 50181-0042 | ORAL | 12 [hp_X] in 1 mL | 5/28/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
Authorised | 5/5/2006 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
Priorix-Tetra | SIN13627P | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ≥ 10³ CCID50/dose | 4/3/2009 | |
Priorix-Tetra | SIN13627P | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | ≥ 10³ CCID50/dose | 4/3/2009 | |
PRIORIX VACCINE | SIN10822P | INJECTION, POWDER, FOR SOLUTION | min 1000 TCID50 | 3/22/1999 | |
ProQuad Refrigerator Stable Formulation | SIN13563P | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3.00 log TCID 50/ dose | 10/23/2008 | |
M-M-R II VACCINE | SIN02056P | INJECTION, POWDER, FOR SOLUTION | min 1000 CCID50/0.5 ml | 6/24/1988 | |
ACAM2000 | SIN13748P | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1.0 x10⁸ - 5.0 x10⁸ PFU/ml | 12/28/2009 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
PROQUAD VACCINE | N/A | N/A | N/A | 10/5/2006 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
PRIORIX ALBUMIN FREE VACCINE 0.5mL powder for injection vial and diluent syringe | 97842 | Medicine | A | 11/3/2003 | |
PRIORIX-TETRA Vaccine 0.5mL powder for injection vial with diluent syringe | 107286 | Medicine | A | 11/16/2005 | |
M-M-R II powder for injection vial with diluent pre-filled syringe, single dose | 201877 | Medicine | A | 12/12/2012 | |
M-M-R II Powder for Injection Vial with Diluent Vial, single dose | 118449 | Medicine | A | 2/14/2006 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with sterile diluent vial composite pack | 337388 | Medicine | A | 8/12/2020 | |
M-M-R II Powder for Injection Vial, single dose | 118451 | Medicine | A | 2/14/2006 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial | 126153 | Medicine | A | 2/8/2007 | |
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with prefilled diluent syringe | 126157 | Medicine | A | 2/8/2007 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
MEASLES VIRUS VACCINE, LIVE, ATTENUATED (DRIED) | connaught laboratories ltd. | 02215675 | Powder For Solution
,
Liquid
,
Kit - Subcutaneous | 1000 UNIT / KIT | 12/11/1996 |
MORU-VIRATEN BERNA VACCINE | swiss serum and vaccine institute berne | 02211017 | Powder For Solution
,
Liquid - Subcutaneous | 1 DOSE / KIT | 3/7/1996 |
MEASLES VIRUS VACC LIVE ATT FREEZ DRIED INJ | iaf biovac inc. | 01915282 | Powder For Solution - Subcutaneous | 1000 UNIT / VIAL | 12/31/1991 |
PRIORIX-TETRA | 02297884 | Powder For Solution - Intramuscular
,
Subcutaneous | 1000 CCID50 / 0.5 ML | 6/4/2008 | |
PRIORIX | 02239208 | Kit
,
Powder For Solution - Intramuscular
,
Subcutaneous | 1000 CCID50 / 0.5 ML | 12/4/1998 | |
MEASLES VIRUS VACCINE LIVE ATTEN DRIED | connaught laboratories ltd. | 00524999 | Powder For Solution - Subcutaneous | 1000 UNIT / .5 ML | 12/31/1982 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.